UnitedHealth, Medicare
Digest more
Mizuho's Jared Holz joins 'Fast Money' to talk the future of UnitedHealth after the stock slides on news of DOJ probe.
UnitedHealth Group is scheduled to report second-quarter results on Tuesday morning, capping a tumultuous first half of the year for the health insurance giant.
Stocks were mixed Thursday. The Dow Jones Industrial Average fell more than 300 points after Honeywell and International Business Machines slumped on quarterly earnings updates, and as UnitedHealth Group traded lower after saying it was “complying with formal criminal and civil requests” from the U.
Jeff Jonas, Gabelli portfolio manager, and John Ransom, Raymond James director of healthcare research, join 'Power Lunch' to discuss each expert's thoughts on UnitedHealth amid its recent plunge.
UNH braces for a 27% earnings drop in Q2 as soaring medical costs, margin pressure and investor jitters weigh on performance.
Explore more
13hon MSN
UnitedHealth Is Approaching a Pivotal Moment. Should Investors Buy the Stock Before July 29?
Disappointing second-quarter results from Elevance Health might not bode well for UnitedHealth Group. UnitedHealth Group could calm investors with new full-year guidance and details on how it will return to growth.
UnitedHealth Group is currently undervalued due to an overblown market reaction to profitability challenges. Click here to find out why UNH is a Strong Buy.
We recently published 12 Stocks Jim Cramer Talked About. UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer recently discussed. UnitedHealth Group Incorporated (NYSE:UNH) is one of the largest healthcare benefits providers in America.